FindTrial
Sign In

The effects of dexmedetomidine on cardiac electrophysiology in adults - Dexmedetomidine and cardiac physiology

The effects of dexmedetomidine on cardiac electrophysiology in adults - Dexmedetomidine and cardiac physiology

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2010-020782-24-FI
Enrollment
Unknown
Registered
2010-10-18
Start date
2010-11-24
Completion date
Unknown
Last updated
2012-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial electrophysiology of the patients with paroxysmal atrial fibrillation MedDRA version: 12.1 Level: LLT Classification code 10003658 Term: Atrial fibrillation

Interventions

Trade Name: Deksmedetomidiini (Precedex) Product Name: Precedex Pharmaceutical Form: Intravenous infusion INN or Proposed INN: dexmedetomidine hydrochloride

Sponsors

Helsinki University Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. patients with paroxysmal atrial fibrillation 2. radiofrequency ablation of atrial fibrillation Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: 1. allergy to dexmedetomidine, opioid analgesics or benzodiazepines 2. age > 65 yrs 3. severe hypotonia

Design outcomes

Primary

MeasureTime frame
Main Objective: The effects of dexmedetomidine on cardiac electrophysiology;Secondary Objective: ;Primary end point(s): electrophysiological measurements before and after dexmedetomidine—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026